ARDXArdelyx, Inc.
$3.28-47% 1Y
$3.28
$3.2652 weeks$7.99
The financials
Ardelyx, Inc. by the numbers
Ardelyx, Inc. (ARDX) reported revenue of $121M in Q2 2026 (quarter ended Jun 30, 2026), up 24% from the same quarter a year earlier. That came with a gross margin of 95% and net loss of $17M. For the full year FY2025, revenue was $407M (+22% year on year) and net income −$62M. Its largest product in Q2 2026 was Product IBSRELA at $86M, 70% of the disclosed total, well ahead of Product XPHOZAH at 26%. The next results filing is expected around Oct 29, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $121M | $98M | +24% |
| Gross profit | $115M | $85M | +35% |
| Operating income | −$12M | −$14M | n/a |
| Net income | −$17M | −$19M | n/a |
| Diluted EPS | −$0.07 | −$0.08 | n/a |
| Product | Revenue | Share |
|---|---|---|
| Product IBSRELA | $86M | 70% |
| Product XPHOZAH | $32M | 26% |
| Product And Service Other | $2.7M | 2.2% |
| Product Supply | $2.0M | 1.6% |
| Non Cash Royalty Related To Sale Of Future Royalties | $676K | 0.5% |
| License | $96K | 0.1% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $123.6M (+29%)
License grew +380% year on yearProduct Supply -68% year on year
Segment Latestquarter on quarteryear on year
- Product IBSRELA$86.2M$86.2Mquarter on quarter +23%year on year +33%+23%+33%
- Product XPHOZAH$31.9M$31.9Mquarter on quarter +37%year on year +27%+37%+27%
- Product And Service Other$2.7M$2.7Mquarter on quarter +150%year on year -64%+150%-64%
- Product Supply$2.0M$2.0Mquarter on quarter +458%year on year -68%+458%-68%
- Non Cash Royalty Related To Sale Of Future Royalties$676.0K$676.0Kquarter on quarter -2.7%year on year -51%-2.7%-51%
- License$96.0K$96.0Kquarter on quarter +88%year on year +380%+88%+380%
On our screens:Most shorted stocks